An opinion piece in the New York Times explores an issue that emerged in the course of a trial over DePuy Orthopaedics’ ASR hip implants – doctors who remain silent over harmful medical devices or drugs.
Although experts say doctors have an ethical responsibility to speak out in such cases, they often fail to warn their colleagues, the New York Times reports.
In the case of DePuy Orthopaedics, a subsidiary of Johnson ...
continue reading...
A blog entry for the Philadelphia Inquirer notes that vaginal mesh implants, like the kind that recently served as the basis of an $11.1 million jury award in New Jersey, were initially marketed as a safer alternative for women suffering from pelvic organ prolapse.
Instead, thousands of patients who received the implants complained of complications including severe pain, infections and bleeding.
Pelvic organ prolapse occurs when a pelvic ...
continue reading...
A new study funded by the U.S. Food and Drug Administration reports that artificial hip implants are more likely to prematurely fail and need replacement for female patients, according to a CBS News story.
The story says researchers at Weill Cornell Medical College in New York City analyzed the results for 35,000 hip implant recipients. They found that women were almost 30 percent more likely than men to need a repeat ...
continue reading...A blog entry on Consumer Reports recommends that patients taking the diabetes medications Byetta or Januvia ask their doctors about possibly taking other medications.
According to Consumer Reports, people taking those two drugs may have a small but increased risk for a condition marked by stomach pain and nausea. More troubling, a new study in JAMA Internal Medicine links both drugs with an increased risk of an inflamed pancreas, called pancreatitis. The researchers noted that pancreatitis is a risk factor for ...
continue reading...An editorial in the Newark Star Ledger titled “Another black eye for J&J” says that Johnson & Johnson’s actions with regards to its ASR hip replacement were not only unethical, but would have landed an individual in prison.
Johnson & Johnson recalled the implants, made by subsidiary DePuy Orthopaedics, in 2010 after studies showed that nearly half of them broke down ...
continue reading...A Los Angeles jury has awarded $8.3 million in damages to a man who claims he suffered metal poisoning from an artificial hip implant manufactured by Johnson & Johnson’s DePuy Orthopedics division.
The case is the first to go to trial of more than 10,000 involving DePuy’s ASR hip implant. According to a Bloomberg article, analysts predict that all of the lawsuits may end up costing Johnson & Johnson billions of ...
continue reading...
